| 3TC | Lamivudine |
| ABC | Abacavir |
| ANOVA | Analysis of variance |
| ART | Antiretroviral therapy |
| ARV | Antiretroviral drug |
| AZT | Zidovudine |
| d4T | Lamivudine |
| ddI | Didanosine |
| DMEM | Dulbecco’s modified Eagle medium |
| DOR | Doravirine |
| dNTP | Deoxyribonucleotide triphosphate |
| FC | Fold change |
| FTC | Emtricitabine |
| HIV-1 | Human immunodeficiency virus type-1 |
| HEK | Human embryonic kidney |
| HEPES | 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid |
| IC50 | Inhibitory concentration-50 |
| ISL | Islatravir |
| _Rev | Reversion of M184V to M184) |
| LB | Luria-Bertani |
| NNRTI | Non-nucleoside reverse transcriptase inhibitor |
| NRTI | Nucleos(t)ide reverse transcriptase inhibitor |
| NRTtI | Nucleoside reverse transcriptase translocation inhibitor |
| PCR | Polymerase chain reaction |
| PEImax | Polyethylenimine-max |
| PLWH | People living with HIV |
| RLU | Relative light units |
| RT | Reverse transcriptase |
| SD | Standard deviation |
| SEM | Standard error of the mean |
| SOB | Super optimal broth |
| TAM2 | Thymidine analogue mutation type 2 |
| TCO | Technical cutoff |
| TNF | Tenofovir |
| VSV-G | Vesicular stomatitis virus glycoprotein |